News & Events category:
NIHR Manchester Biomedical Research Centre

A world-first genetic test, developed in Manchester, that could save the hearing of hundreds of babies each year has been successfully piloted in the NHS.

Three budding MFT entrepreneurs have been awarded places on the prestigious NHS Clinical Entrepreneur Programme.

The results of the world’s first Phase 3 trials, of a new drug Gefapixant, show that it can ease the often distressing symptoms of chronic cough, with minimal side effects.

The NIHR Immune Mediated Inflammatory Disease (IMID) BioResource recently hit a major recruitment milestone of 2000 volunteers, thanks to the collaborative effort of centres across England.

The first participants have been involved in a study onboard Greater Manchester’s new state-of-the-art Research Van. 

Participation in research studies is about to become easier than ever for residents across Greater Manchester thanks to the arrival of our state-of-the-art Research Van.

Results from a COVID-19 vaccine trial – to which MFT consented the first global participant – are ‘extremely positive’.

Research led by Professor Bill Newman, Consultant at MFT, could revolutionise the diagnosis and treatment for people with Perrault syndrome.